White matter changes from mild cognitive impairment to Alzheimer’s disease: a meta-analysis

被引:0
作者
Linzi Qin
Zhiwei Guo
Morgan A. McClure
Qiwen Mu
机构
[1] The Second Clinical Medical College of North Sichuan Medical College,Department of CT/MRI, Institute of Rehabilitation and Imaging of Brain Function
[2] Southwest Medical University,Department of Medical Imaging
[3] Peking University Third Hospital,Department of Radiology
来源
Acta Neurologica Belgica | 2021年 / 121卷
关键词
Mild cognitive impairment; Alzheimer’s disease; Diffusion tensor imaging; Fractional anisotropy; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
Previous diffusion tensor imaging (DTI) studies have reported that both mild cognitive impairment (MCI) and Alzheimer’s disease (AD) revealed microstructural changes [fractional anisotropy (FA)]. However, these results were not conclusive. The purpose of this meta-analysis was to identify the consistent FA alterations and the differences between MCI and AD. Case–control studies investigating MCI and AD using FA were searched in the online databases. The quantitative FA value of cognition-related brain regions was extracted and the standardized mean difference (SMD) with 95% confidence interval (CI) was calculated using fixed or random effect models. Twenty six studies with a total of 1,021 patients were included in this meta-analysis. Significantly decreased FA in patients with AD were identified in the left frontal lobe, corpus callosum (CC), fornix, hippocampus (HP), cingulate gyrus (CG), cingulate bundle (CB), uncinate fasciculus (UF), superior longitudinal fasciculus(SLF), the inferior fronto-occipital fascicles (IFOF), and the inferior longitudinal fasciculus(ILF) relative to MCI in this meta-analysis. This study provides objective and quantitative evidence that AD is associated with FA alteration within left frontal lobe, CC, FX, HP, CG, CB, and UF may suggest the key regions of the process from MCI to AD.
引用
收藏
页码:1435 / 1447
页数:12
相关论文
共 315 条
[1]  
Nowrangi MA(2011)Epidemiology, assessment, and treatment of dementia Psychiatr Clin N Am 34 vii-152
[2]  
Rao V(2011)Epidemiology of Alzheimer disease Nat Rev Neurol 7 137-1083
[3]  
Lyketsos CG(2009)Alzheimer's disease: a global challenge for the 21st century Lancet Neurol 8 1082-333
[4]  
Reitz C(2014)Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease N Engl J Med 370 322-321
[5]  
Brayne C(2014)Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease N Engl J Med 370 311-194
[6]  
Mayeux R(2004)Mild cognitive impairment as a diagnostic entity J Intern Med 256 183-788
[7]  
Dartigues JF(2018)Estimating Alzheimer's disease progression rates from normal cognition through mild cognitive impairment and stages of Dementia Curr Alzheimer Res 15 777-876
[8]  
Salloway S(2012)Enhancing memory performance with rTMS in healthy subjects and individuals with Mild Cognitive Impairment: the role of the right dorsolateral prefrontal cortex Front Hum Neurosci 6 62-61
[9]  
Sperling R(2018)Menopausal hormone therapy and mild cognitive impairment: a randomized, placebo-controlled trial Menopause 25 870-18
[10]  
Fox NC(2008)Diffusion tensor imaging (DTI)-based white matter mapping in brain research: a review J Mol Neurosci 34 51-113